<code id='7B981FFFE9'></code><style id='7B981FFFE9'></style>
    • <acronym id='7B981FFFE9'></acronym>
      <center id='7B981FFFE9'><center id='7B981FFFE9'><tfoot id='7B981FFFE9'></tfoot></center><abbr id='7B981FFFE9'><dir id='7B981FFFE9'><tfoot id='7B981FFFE9'></tfoot><noframes id='7B981FFFE9'>

    • <optgroup id='7B981FFFE9'><strike id='7B981FFFE9'><sup id='7B981FFFE9'></sup></strike><code id='7B981FFFE9'></code></optgroup>
        1. <b id='7B981FFFE9'><label id='7B981FFFE9'><select id='7B981FFFE9'><dt id='7B981FFFE9'><span id='7B981FFFE9'></span></dt></select></label></b><u id='7B981FFFE9'></u>
          <i id='7B981FFFE9'><strike id='7B981FFFE9'><tt id='7B981FFFE9'><pre id='7B981FFFE9'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:857
          Cosmetics
          Alberto Pellaschiar/AP

          WASHINGTON — For those already felled by fumes from the Brazilian Blowout, it might be small consolation, but lawmakers are pushing ahead with a campaign for better oversight of the beauty business.

          Despite its booming growth, the cosmetics industry in the US has been virtually unregulated. The Food, Drug, and Cosmetic Act, adopted in 1938, essentially allowed personal care product companies to self-police.

          advertisement

          But rising public concern over bad reactions to makeup, hair dyes, and fragrances, as well as evidence of long-term health risks from some of their chemical contents, has led lawmakers to try to toughen the regulatory framework for the $60 billion enhancement industry.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more
          Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT
          Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Anxious about a speech? A startup wants you to pop a minty cardiac drug

          APSTockThepillworkslikemagic,peoplewho’veuseditsay,toquelltheiranxietyaroundpublicspeaking.Fordecade